Agile Therapeutics
AGRX
#10812
Rank
โ‚ฌ9.04 M
Marketcap
1,31ย โ‚ฌ
Share price
0.00%
Change (1 day)
324.39%
Change (1 year)

EPS for Agile Therapeutics (AGRX)

EPS in 2024 (TTM): -3,58ย โ‚ฌ

According to Agile Therapeutics 's latest financial reports the company's current EPS (TTM) is -3,36ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -205,58ย โ‚ฌ an increase over its 2021 EPS that were of -1.353ย โ‚ฌ.

EPS history for Agile Therapeutics from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-3,58ย โ‚ฌ
2022-205,58ย โ‚ฌ-84.81%
2021-1.353ย โ‚ฌ30%
2020-1.041ย โ‚ฌ53.85%
2019-676,65ย โ‚ฌ-32.76%
2018-1.006ย โ‚ฌ
2016-1.752ย โ‚ฌ-26.28%
2015-2.377ย โ‚ฌ21.79%
2014-1.952ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,58ย โ‚ฌ-325.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,14ย โ‚ฌ-133.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
3,10ย โ‚ฌ-192.37%๐Ÿ‡บ๐Ÿ‡ธ USA
TherapeuticsMD
TXMD
0,008675ย โ‚ฌ-100.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
0,29ย โ‚ฌ-108.79%๐Ÿ‡บ๐Ÿ‡ธ USA